ERBB2 and neoplasm: Testing criteria define HER2 positive status when (on observing within an area of tumor that amounts to >10% of contiguous and homogeneous tumor nuclei) there is evidence of HER2 gene amplification based on counting at least 20 nuclei within this area14.